Expression of CMTM6 was reported to limit anti-tumor immunity29,30 via regulating abundance and localization of programmed death ligand-1 (PDL1/CD274) at the surface of cancer cells, at least in vitro. The gene discussed is CMTM6; the disease is neoplasm.